QQQ   270.65 (-1.45%)
AAPL   444.31 (-2.48%)
MSFT   211.70 (-2.15%)
FB   270.05 (+1.80%)
GOOGL   1,496.75 (-0.54%)
AMZN   3,162.76 (-1.93%)
NVDA   445.46 (-1.76%)
CGC   16.83 (-3.94%)
BABA   248.55 (-6.45%)
TSLA   1,436.04 (-3.59%)
MU   48.26 (-0.90%)
GE   6.39 (+0.95%)
AMD   83.36 (-3.86%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.12 (-1.84%)
GILD   69.02 (+0.31%)
NFLX   490.47 (-3.66%)
DIS   130.62 (-0.15%)
BAC   26.18 (+2.79%)
BA   170.11 (-1.21%)
QQQ   270.65 (-1.45%)
AAPL   444.31 (-2.48%)
MSFT   211.70 (-2.15%)
FB   270.05 (+1.80%)
GOOGL   1,496.75 (-0.54%)
AMZN   3,162.76 (-1.93%)
NVDA   445.46 (-1.76%)
CGC   16.83 (-3.94%)
BABA   248.55 (-6.45%)
TSLA   1,436.04 (-3.59%)
MU   48.26 (-0.90%)
GE   6.39 (+0.95%)
AMD   83.36 (-3.86%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.12 (-1.84%)
GILD   69.02 (+0.31%)
NFLX   490.47 (-3.66%)
DIS   130.62 (-0.15%)
BAC   26.18 (+2.79%)
BA   170.11 (-1.21%)
QQQ   270.65 (-1.45%)
AAPL   444.31 (-2.48%)
MSFT   211.70 (-2.15%)
FB   270.05 (+1.80%)
GOOGL   1,496.75 (-0.54%)
AMZN   3,162.76 (-1.93%)
NVDA   445.46 (-1.76%)
CGC   16.83 (-3.94%)
BABA   248.55 (-6.45%)
TSLA   1,436.04 (-3.59%)
MU   48.26 (-0.90%)
GE   6.39 (+0.95%)
AMD   83.36 (-3.86%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.12 (-1.84%)
GILD   69.02 (+0.31%)
NFLX   490.47 (-3.66%)
DIS   130.62 (-0.15%)
BAC   26.18 (+2.79%)
BA   170.11 (-1.21%)
QQQ   270.65 (-1.45%)
AAPL   444.31 (-2.48%)
MSFT   211.70 (-2.15%)
FB   270.05 (+1.80%)
GOOGL   1,496.75 (-0.54%)
AMZN   3,162.76 (-1.93%)
NVDA   445.46 (-1.76%)
CGC   16.83 (-3.94%)
BABA   248.55 (-6.45%)
TSLA   1,436.04 (-3.59%)
MU   48.26 (-0.90%)
GE   6.39 (+0.95%)
AMD   83.36 (-3.86%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.12 (-1.84%)
GILD   69.02 (+0.31%)
NFLX   490.47 (-3.66%)
DIS   130.62 (-0.15%)
BAC   26.18 (+2.79%)
BA   170.11 (-1.21%)
Log in

FRA:EVKEvonik Industries Stock Price, Forecast & News

€24.16
-0.17 (-0.70 %)
(As of 08/7/2020 02:13 PM ET)
Add
Compare
Today's Range
€24.02
Now: €24.16
€24.69
50-Day Range
€22.13
MA: €23.68
€24.93
52-Week Range
€26.78
Now: €24.16
€32.97
Volume462,073 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products. The Resource Efficiency segment provides high-performance materials and specialty additives, such as hydrogen peroxide, activated nickel catalysts, precious metal powder catalysts, oil and fat hydrogenation catalysts, amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, organically modified silicones, isophorone chemistry, PEEK, polyamide 12, oil additives, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, precipitated silicas, and matting agents for the automotive, paints, coatings, adhesives, construction, and various other sectors. The Performance Materials segment produces polymer materials and intermediates, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, TAA and TAA derivatives, and methacrylate monomers and polymers for rubber, plastics, and agriculture industries. The Services segment provides site management, utilities and waste management, technical, process technology, engineering, and logistics services. The company is headquartered in Essen, Germany. Evonik Industries AG is a subsidiary of RAG-Stiftung.
Read More
Evonik Industries logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.98 out of 5 stars


Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+49-201-17701

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees36,043
Next Earnings DateN/A
OptionableNot Optionable
€24.16
-0.17 (-0.70 %)
(As of 08/7/2020 02:13 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EVK News and Ratings via Email

Sign-up to receive the latest news and ratings for EVK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Evonik Industries (FRA:EVK) Frequently Asked Questions

How has Evonik Industries' stock been impacted by COVID-19 (Coronavirus)?

Evonik Industries' stock was trading at €20.55 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EVK shares have increased by 17.6% and is now trading at €24.16.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Evonik Industries?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evonik Industries in the last year. There are currently 3 sell ratings, 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Evonik Industries
.

What price target have analysts set for EVK?

17 brokerages have issued 1-year price objectives for Evonik Industries' stock. Their forecasts range from €20.00 to €33.00. On average, they anticipate Evonik Industries' stock price to reach €25.34 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price.
View analysts' price targets for Evonik Industries
.

Has Evonik Industries been receiving favorable news coverage?

News coverage about EVK stock has trended positive this week, according to InfoTrie. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Evonik Industries earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Evonik Industries
.

Who are some of Evonik Industries' key competitors?

What other stocks do shareholders of Evonik Industries own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evonik Industries investors own include Nordson (NDSN), Old Mutual (OML), Univar (UNVR), Zscaler (ZS), Asbury Automotive Group (ABG), Amplify Energy (AMPY), Amplify Energy (AMPY), Arista Networks (ANET), Ascendis Pharma A/S (ASND) and Yamana Gold (AUY).

Who are Evonik Industries' key executives?

Evonik Industries' management team includes the following people:
  • Mr. Christian Kullmann, CEO & Chairman of the Exec. Board (Age 50)
  • Dr. Harald Schwager, Deputy Chairman of the Exec. Board (Age 59)
  • Ms. Ute Wolf, CFO & Member of Exec. Board (Age 51)
  • Mr. Thomas Wessel, Chief Human Resource Officer, Industrial Relations Director & Member of Exec. Board (Age 56)
  • Dr. Wilfried Ostendorf, Head of Production and Technology

What is Evonik Industries' stock symbol?

Evonik Industries trades on the FRA under the ticker symbol "EVK."

What is Evonik Industries' stock price today?

One share of EVK stock can currently be purchased for approximately €24.16.

What is Evonik Industries' official website?

The official website for Evonik Industries is corporate.evonik.de.

How can I contact Evonik Industries?

Evonik Industries' mailing address is Rellinghauser Strasse 1-11, ESSEN, 45128, Germany. The company can be reached via phone at +49-201-17701.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.